{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1\/2, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients With Intermediate or High-Risk Primary or Secondary Myelofibrosis","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-2-open-label-dose-escalation-safety-pharmacokinetic-and-pharmacodynamic-study-of-oral-tp-3654-in-patients-with-intermediate-or-high-risk-primary-or-secondary-myelofibrosis\/#breadcrumbitem"}]}